Aspire Biopharma Provides Q3 2025 Business Update

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

InstaMed® Pharmaceuticals Announces Month-Over-Month Hypergrowth, Successful Study, and Expands Its Patented Peptide Delivery Platform Nationwide

InstaMed® Pharmaceuticals, a biotechnology innovator, is pioneering the first patented non-injectable peptide delivery system ...

Antibody formulation could enable simple injections instead of lengthy hospital infusions

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...
ABC4 Utah

Nevada man sentenced for distributing drugs that resulted in death of Utah resident

A man from Las Vegas Nevada was sentenced today after distributing fentanyl by mailing it to a Utah woman, who died from ...
American Association of Individual Investors

Which Is a Better Investment, Nurix Therapeutics, Inc. or Recursion Pharmaceuticals, Inc. Stock?

Learn more about whether Nurix Therapeutics, Inc. or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

ContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners Credit

Marks the first step in building ContextLogic into a differentiated business ownership platform. ContextLogic will be focused on owning niche, ...

Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...